Juvenile myasthenia gravis is rare, representing just 10% of all myast
henia gravis, Treatment of the juvenile form is similar to the adult f
orm, although concerns of long-term side effects limit use of immunomo
dulators and thymectomy in children, especially the very young, We rev
iew the clinical course of three children with juvenile myasthenia gra
vis, as well as the current status of intravenous immunoglobulin and t
hymectomy as treatments for juvenile myasthenia gravis. (C) 1998 by El
sevier Science Inc. All rights reserved.